• A
  • A
  • A
日本語 Help
Science and technology information site for articles, patents, researchers information, etc.
Rchr
J-GLOBAL ID:202401014205954712   Update date: Apr. 13, 2025

Itoh Hiroki

イトウ ヒロキ | Itoh Hiroki
Affiliation and department:
Job title: Professor
Research theme for competitive and other funds  (9):
  • 2022 - 2025 Development of useful new biomarkers to predict the severity and prognosis of vasculitis syndrome
  • 2019 - 2024 術後疼痛の症状マネジメントに用いる除痛アルゴリズムと評価指標の構築
  • 2019 - 2022 Development of new biomarkers aimed at proper use of antibacterial agents and improvement of prognosis in patients with febrile neutropenia
  • 2018 - 2022 Development to individualization treatment of Kampo medicine for the side effect with the chemotherapy that intended proper use
  • 2016 - 2019 Development of novel biomarker to individual therapy of nausea and vomitting by chemotherapy
Show all
Papers (182):
  • Ayako Oda, Yosuke Suzuki, Haruki Sato, Teruhide Koyama, Masahiro Nakatochi, Yukihide Momozawa, Ryota Tanaka, Hiroyuki Ono, Ryosuke Tatsuta, Tadasuke Ando, et al. Evaluation of the usefulness of plasma 4β-hydroxycholesterol concentration normalized by 4α-hydroxycholesterol for accurate CYP3A phenotyping. Clinical and translational science. 2024. 17. 3. e13768
  • Chisato Yoshijima, Yosuke Suzuki, Ryota Tanaka, Hiroyuki Ono, Ayako Oda, Takashi Ozaki, Hirotaka Shibata, Hiroki Itoh, Keiko Ohno. Rapid and simple quantification of belimumab in human plasma using ultra-high performance liquid chromatography with tandem mass spectrometry. Clinical biochemistry. 2024. 124. 110706-110706
  • Hiroyuki Ono, Ryota Tanaka, Yosuke Suzuki, Ayako Oda, Haruki Sato, Ryosuke Tatsuta, Tadasuke Ando, Toshitaka Shin, Keiko Ohno, Hiroki Itoh. Relationship of plasma 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease. Clinical and translational science. 2024. 17. 2. e13731
  • Chisato Yoshijima, Yosuke Suzuki, Ayako Oda, Ryota Tanaka, Hiroyuki Ono, Hiroki Itoh, Keiko Ohno. Usefulness of Belimumab in Adult Patients With Systemic Lupus Erythematosus Evaluated Using Single Indexes: A Meta-Analysis and Systematic Review. Current therapeutic research, clinical and experimental. 2024. 100. 100738-100738
  • Yuko Morinaga, Ryota Tanaka, Ryosuke Tatsuta, Kuniko Takano, Takehiro Hashimoto, Masao Ogata, Kazufumi Hiramatsu, Hiroki Itoh. Risk Factors for Teicoplanin-Associated Acute Kidney Injury in Patients with Hematological Malignancies: Focusing on Concomitant Use of Tazobactam/Piperacillin. Biological & pharmaceutical bulletin. 2024. 47. 5. 988-996
more...
MISC (9):
  • 白岩 健, 田中 遼大, 佐藤 雄己, 伊東 弘樹. びまん性大細胞型B細胞リンパ腫に対して化学療法終了12ヵ月以上経過後にB型肝炎ウイルス再活性化を来した一症例. 日本薬剤師会学術大会講演要旨集. 2019. 52回. O-4
  • 森永 裕子, 田中 遼大, 佐藤 雄己, 伊東 弘樹. 抗MRSA薬使用時の血清ナトリウム値の変動に関する検討. 学会誌JSPEN. 2019. 1. Suppl. 1221-1221
  • 佐藤 雄己, 龍田 涼佑, 中原 良介, 田中 遼大, 津下 遥香, 炭本 隆宏, 伊東 弘樹. 不眠症治療薬の種類および服用量と転倒率との関連性. 診療と新薬. 2019. 56. 8. 576-581
  • 佐藤 雄己, 鈴木 陽介, 田中 遼大, 金子 哲也, 伊東 弘樹. 第2回病院薬剤師が実践するリバーストランスレーショナルリサーチの最前線〜分子標的探索と個別化医療への挑戦〜 PK/PD解析及びTDMに基づく抗菌薬療法個別化への臨床的アプローチ. 薬学雑誌. 2019. 139. 6. 917-922
  • 白岩 健, 炭本 隆宏, 鈴木 陽介, 中原 良介, 岩男 元志, 田中 遼大, 佐藤 雄己, 伊東 弘樹. 分子標的抗がん剤による治療に血中濃度をどう活かすか?〜TDMの真価を問う〜 大分大学医学部附属病院における経口抗がん剤の血漿中濃度測定およびその臨床応用. TDM研究. 2019. 36. 2. 76-76
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page